Work

S101 The impact of smoking on improving COPD outcomes with umeclidinium/vilanterol: a pre-specified analysis of the EMAX trial

Year: 2019

Type: conference-abstract

Source: Thorax

DOI: 10.1136/thorax-2019-btsabstracts2019.107

Authors: L Bjermer, IH Boucot, CF Vogelmeier, P Jones, F Maltais, IP Naya, L Tombs, C Compton, DA Lipson, EM Kerwin

Institutions: Lund University, GlaxoSmithKline (United Kingdom), Philipps University of Marburg, Universitätsklinikum Gießen und Marburg, German Center for Lung Research, Université Laval, GlaxoSmithKline (United States)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2989553888

Cites:

Cited by:

Related to: 10